Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study

Background: Pharmacological treatments including antivirals (Lopinavir/Ritonavir), Immuno-modulatory and anti-inflammatory drugs including, Tocilizumab and Hydroxychloroquine (HCQ) has been widely investigated as a treatment for COVID-19.Despite the ongoing controversies, HCQ was recommended for man...

Full description

Saved in:
Bibliographic Details
Main Authors: Saja H. Almazrou, Ziyad S. Almalki, Abdullah S. Alanazi, Abdulhadi M. Alqahtani, Saleh M. Alghamd
Format: Article
Language:English
Published: Springer 2020-12-01
Series:Saudi Pharmaceutical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016420302334
Tags: Add Tag
No Tags, Be the first to tag this record!